Pennsylvania NY NJ Biotech Networks
  • Home
  • About
  • Jobs
    • All Jobs
    • Featured Jobs
    • Post a Job
  • News
    • All News
    • Trending News
  • Subscribe
  • Contact
News Ticker
  • [ March 31, 2023 ] IP/Life Sciences Associate – Greenberg Traurig – Florham Park, NJ Jobs
  • [ March 31, 2023 ] IP/Life Sciences Associate – Greenberg Traurig – New York, NY Jobs
  • [ March 31, 2023 ] IP/Life Sciences Patent Agent – Greenberg Traurig – New York, NY Jobs
  • [ March 31, 2023 ] Fujirebio further extends its fully automated blood-based biomarker portfolio with the fully automated Lumipulse® G ApoE4 and Lumipulse® G Pan-ApoE assays for Research Use Only News
  • [ March 31, 2023 ] Product Director, Oncology Franchise Digital Marketing (Horsham, PA) – Janssen Biotech, Inc. – Johnson & Johnson – Horsham, PA Jobs
HomeNews

News

No Picture
News

Daiichi Sankyo inks $183M discovery deal with GPCR biotech for CNS target

March 30, 2023 PNBN News 0

Belgian biotech Confo Therapeutics has landed $183 million, plus potential royalties, in a drug-discovery deal with Daiichi Sankyo. Early Thursday, Confo Therapeutics put out word of the deal that will be focused on small molecule […]

No Picture
News

Merck to Hold First-Quarter 2023 Sales and Earnings Conference Call on April 27

March 30, 2023 PNBN News 0

RAHWAY, N.J.–(BUSINESS WIRE)—- $MRK #MRK–Merck to Hold First-Quarter 2023 Sales and Earnings Conference Call on April 27 Click here to view original post

No Picture
News

Xeris Biopharma Announces Research Evaluation Collaboration and Option Agreement With Regeneron for XeriJect™

March 30, 2023 PNBN News 0

CHICAGO–(BUSINESS WIRE)– #GvokeHypoPen–Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapeutic areas, today announced that it has entered […]

No Picture
News

BD² Announces First $15 Million in Grants to Advance Genetic and Biological Understanding of Bipolar Disorder

March 30, 2023 PNBN News 0

The Broad Institute of MIT and Harvard, in collaboration with UCLA, and the New York Genome Center to create the BD² Genetics Platform The CommonMind Consortium (Icahn School of Medicine at Mount Sinai, University of […]

No Picture
News

Jefferson receives $15M gift from Humana to advance health equity and community health initiatives

March 30, 2023 PNBN News 0

The bulk of the donation will be used to establish three endowed positions at Thomas Jefferson University. Click here to view original post

No Picture
News

Rothman Orthopaedic Institute’s CEO out after two years in position

March 30, 2023 PNBN News 0

Dr. Christopher Olivia was brought in two years ago to run the 1,800-person Rothman Orthopaedic Institute, the region’s largest orthopedic group. Click here to view original post

No Picture
News

Here’s where UPMC WorkPartners insurer is expanding now

March 29, 2023 PNBN News 0

It’s the latest growth of the UPMC Health Plan unit since it widened past Pennsylvania in 2018. Click here to view original post

No Picture
News

Genentech’s Vabysmo Well-Received Amongst Ophthalmologists, but Use Continues to Lag the Competition, According to Spherix Global Insights

March 29, 2023 PNBN News 0

Despite a very satisfied Vabysmo user-base, Regeneron’s 8mg aflibercept is already highly anticipated by ophthalmologists and likely to throw a wrench into Vabysmo’s positive trajectory. EXTON, Pa., March 29, 2023 /PRNewswire/ — According to Spherix […]

No Picture
News

Q&A: Newly-minted CSL chief executive Paul McKenzie and chief medical officer Bill Mezzanotte

March 29, 2023 PNBN News 0

Paul McKenzie took over as CEO of Australian pharma giant CSL this month, following in the footsteps of long-time CSL vet Paul Perreault. With an eye on mRNA, and quickly commercializing its new, $3.5 million-per-shot gene […]

No Picture
News

Boehringer reports robust sales led by type 2 diabetes and pulmonary drugs, promises more to come highlighting obesity

March 29, 2023 PNBN News 0

Boehringer Ingelheim reported human pharma sales of €18.5 billion on Wednesday, led by type 2 diabetes and heart failure drug Jardiance and pulmonary fibrosis med Ofev. Jardiance sales reached €5.8 billion, growing 39% year over […]

Posts navigation

« 1 2 3 … 441 »

Follow/Subscribe

PNBN Jobs

POST A JOB

PNBN Featured Jobs

Tweets by PNBionetwork

Copyright © 2023 Biotech Networks, LLC

Get Biotech Networks Briefs in Your Inbox: Trending News & Featured Jobs